跳至主要内容
临床试验/ACTRN12605000365662
ACTRN12605000365662已完成3 期

A pilot study to evaluate the potential roles for the topical application of aromatherapy essential oils in the modulation of immune function in healthy individuals

Sharon Kepper Aromatherapy: Fragrantia Investments0 个研究点目标入组 20 人开始时间: 2005年9月12日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
Male

入选标准

  • Willing to comply with study protocols. The smokers must consume 10 cigarettes per day, and have done so for at least a year. The non-smokers must have never smoked.

排除标准

  • Factors resulting in exclusion include: any significant medical problem or chronic illness, including the findings on assessment of:o BMI >30 or <18, o undiagnosed hypertension oro pulse irregularities consistent with pathological cardiac dysrhythmia such as atrial fibrillationHistory of allergies to fragrances, current or recent dermatitis, regular use of medications, vitamin or supplement consumption, alcohol intake of more than 7 standard drinks per week or greater than 4 on heaviest day, high levels of exercise (extreme strenuous exercise for over 60 mins >twice per week) Recreational drug use, any acute illness or infection in the preceding 2 weeks.

研究者

发起方
Sharon Kepper Aromatherapy: Fragrantia Investments

相似试验